Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1987;75:229-234

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lang, R. M.
Right arrow Articles by Borow, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, R. M.
Right arrow Articles by Borow, K. M.

Circulation, Vol 75, 229-234, Copyright © 1987 by American Heart Association


ARTICLES

Contrast ultrasonography of the kidney: a new method for evaluation of renal perfusion in vivo

RM Lang, SB Feinstein, SM Powsner, CE McCoy, ED Frederickson, A Neumann, LI Goldberg and KM Borow

Assessment of the effects of pharmacologic agents on renal blood flow (RBF) is clinically important in many disease states, including hypertension and congestive heart failure. However, because of the complexities of RBF, quantitation in vivo has been technically difficult. This study demonstrates the utility of ultrasound imaging of the kidney combined with injection of a sonicated radiocontrast solution (Renografin-76) for the assessment of regional renal blood flow. The technique uses a suspension of uniform microbubbles (diameter 4.4 +/- 2.8 micron), which when injected directly into the descending aorta are distinctly visualized by renal ultrasound. Five dogs were studied. Catheters were placed in the descending aorta for injection of sonicated Renografin and in the renal artery for drug infusions. Data were collected before and during intrarenal artery infusions of bradykinin and norepinephrine. Total RBF was measured by electromagnetic flowmeter. Video density time curves were generated for comparable segments of the outer renal cortex and fit to a monoexponential decay curve. This allowed calculation of the mean exponential decay index (t1/2). An increase in t1/2 paralleled decreased renal perfusion (i.e., longer washout of contrast material). The opposite was true for a decrease in t1/2. Bradykinin increased RBF from 134 +/- 26 to 249 +/- 19 ml/min (p less than .01 vs control), and norepinephrine decreased RBF from 130 +/- 25 to 51 +/- 17 ml/min (p less than .01 vs control).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. B. Feinstein
The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H450 - H457.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Wei, E. Le, J.-P. Bin, M. Coggins, J. Thorpe, and S. Kaul
Quantification of renal blood flow with contrast-enhanced ultrasound
J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1135 - 1140.
[Abstract] [Full Text] [PDF]